Quick answer
Peptara Labs has published one BPC-157 lot, BPC-260408-A, at 99.04% HPLC purity on certificate COA-2026-8642, tested in June 2026 by Titreon Analytical, with a Janoshik endotoxin report alongside it. BPC-157 has no approved human use anywhere. Each of the two reports opens on the website of the laboratory that issued it.
Delivery terms, rating and testing as published by Peptara Labs. Discount terms are set by Peptara Labs.
5 min readUpdated 15 September 2026Research and educational reading only
A peptide with a large animal literature and very little human data, described here without any result.
BPC-157 is a pentadecapeptide, a chain of fifteen amino acids, first isolated from human gastric juice. The published literature discusses it almost entirely through laboratory and animal models.
Source: PubMed 40005999
BPC-157 has no approved human use in any country on the record this guide follows. Peptara Labs sells it as research-grade material and says no product it sells has been evaluated by the FDA.
Source: the Peptara Labs website, read 14 September 2026
Human evidence is limited to small uncontrolled reports: one retrospective chart review of sixteen patients and one pilot in two adults. No completed randomized controlled trial in humans reports an outcome, and this guide reports none.
Sources: PubMed 34324435, PubMed 40005999
As published by Peptara Labs, which describes Titreon Analytical as aligned to ISO/IEC 17025:2017, not itself accredited. This site has not tested this lot. Source: peptaralabs.io/coa
BPC-157 is one of the lots with a second bacterial endotoxin report from Janoshik, report number 195514, analysed on 30 June 2026. Two documents therefore exist for this lot, and each opens at its source: the certificate on titreonanalytical.com, the report on verify.janoshik.com.
Sources: peptaralabs.io/trust, peptaralabs.io/coa, the Peptara Labs website, read 14 September 2026
What to read before a BPC-157 order, from the lot to the guarantee.
Lot BPC-260408-A, at 99.04% HPLC purity on certificate COA-2026-8642, tested in June 2026 by Titreon Analytical, with a Janoshik endotoxin report alongside it.
No, in no country on the record this guide follows. Peptara Labs sells it as research-grade material and says no product it sells has been evaluated by the FDA.
Yes. A Janoshik bacterial endotoxin report, number 195514, is published for lot BPC-260408-A, analysed on 30 June 2026.
Peptara Labs says its vials ship unlabeled on purpose and that no lot is printed on them. The paperwork travels with the order instead, since its list of what arrives includes a printed certificate for the batch.
Legality is a question this guide hands off rather than answers. Peptara Labs covers the question on its page Are peptides legal in Vietnam?
Is BPC-157 legal in Vietnam? This guide does not give legal guidance. Peptara Labs covers it on its page Are peptides legal in Vietnam?
Three questions about the documents behind a Peptara Labs order. Each answer links its source. This site has not tested any product.
Yes, one per product on its certificates page, each from a recent batch with its lot code, HPLC purity and test date. Its website also lists the printed batch certificate for what shipped among what arrives.
Sources: peptaralabs.io/coa, the Peptara Labs website, read 15 September 2026
By its description: identity by HPLC and LC-MS, HPLC purity against a 95.0 percent release criterion, net peptide content, sterility, bacterial endotoxin, heavy metals and a fentanyl screen.
Source: peptaralabs.io/coa
Yes. Each Titreon certificate has a QR code and a printed key that open it on titreonanalytical.com, and each Janoshik endotoxin report opens on verify.janoshik.com. This guide checked both on 15 September 2026.
Sources: peptaralabs.io/coa, titreonanalytical.com, verify.janoshik.com